Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Medicinova Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −5 vs. Q1 2025
- Shares held
- 5.17M
- −31.6K (−0.6%) vs. Q1 2025
- Total value
- $6.77M
- −$821.1K (−10.8%) vs. Q1 2025
- New holders
- 0
- 4 more added
- Sold out
- 5
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $1.45M | 0.52% | 00.0% | Unchanged |
| BlackRock, Inc. | 695,715 | $911.4K | 0.00% | −4,626−0.7% | Reduced |
| Vanguard Group Inc | 686,577 | $899.4K | 0.00% | +63,003+10.1% | Added |
| Citigroup Inc | 591,957 | $775.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 525,892 | $689.1K | 0.00% | −1,107−0.2% | Reduced |
| Susquehanna International Group, LLP | 250,343 | $327.9K | 0.00% | +228+0.1% | Added |
| UBS Group AG | 222,200 | $291.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 178,700 | $234.1K | 0.00% | −3,000−1.7% | Reduced |
| State Street Corp | 174,598 | $228.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 139,738 | $183.1K | 0.00% | −1,013−0.7% | Reduced |
| Barclays PLC | 108,000 | $141.5K | 0.00% | +33,900+45.7% | Added |
| Bank of New York Mellon Corp | 96,174 | $126.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 94,452 | $123.7K | 0.00% | −35,528−27.3% | Reduced |
| Bridgeway Capital Management, LLC | 76,031 | $99.6K | 0.00% | −25,000−24.7% | Reduced |
| Charles Schwab Investment Management Inc | 71,506 | $93.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 66,215 | $86.7K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 43,479 | $57.0K | 0.00% | −12,600−22.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 34,750 | $45.5K | 0.00% | −388−1.1% | Reduced |
| Hantz Financial Services, Inc. | 4,300 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,462 | $4.54K | 0.00% | +234+7.2% | Added |
| BNP Paribas Arbitrage, SA | 412 | $540 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 305 | $400 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 76 | $100 | 0.00% | −8,600−99.1% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,710−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −10,264−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |